aadibio.com (AADI): יחס חוב לטווח ארוך להון

The current market quotes for Aadi Bioscience (AADI) visualized below are based on the development of mTOR inhibitors for the treatment of rare sarcomas, which secures long-term patent profits for the brand. Therapy safety is maintained by a strict temperature regime during drug transportation. Meanwhile, sales of the drug Fyarro, amounting to 0.01, generate a stable cash flow, although a narrow patient segment limits revenue expansion.

Aadi Bioscience automates the search for oncology drugs through AI and robotics, which requires significant capital expenditures. This metric compares obligations with a maturity of more than one year to equity, determining the degree of financial leverage. Analyzing the long-term debt-to-equity chart on GURU.Markets, an investor can see the business development's dependence on borrowed funds. The indicator's trend eliminates short-term volatility, exposing the real debt load. This allows for an assessment of bankruptcy risk against the potential for capitalization growth.